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Monocyte/macrophages are important components of cell-
mediated immune responses in presentation of antigen, as 
regulators of lymphocyte function, and as sources of cyto-
kines that modulate functions of cells other than those of the 
immune system. Their role in the pathogenesis of alopecia 
areata (AA) and universalis (AU) has not been explored. This 
study is an investigation of the function of peripheral blood 
monocytes from normal subjects and patients with AA, AU, 
and alopecia total is (AT), with respect to the principal macro-
phage-derived angiogenic factor, tumor necrosis factor a 
(TNFa). Because neovascularization is a necessary compo-
nent in the anagen phase of hair growth and may play a role in 
the pathology of these disorders, we asked whether mono-
cyte/macrophage angiogenic activity was compromised in 
T he group of alopecias that include alopecia areata (AA), totalis (AT), and universalis (AU) are generally believed to be autoimmune processes. The presence of T-helper-cell infiltrates [1,2], the expression ofHLA ABC [3] and HLA DR (3,4] antigens on keratino-
cytes, and the prominence ofintrabulbar Langerhans cells (5,6] sup-
port this view. However, pathogenic mechanisms have not been 
entirely elucidated. Although abnormalities in circulating lympho-
cytes have been described, specific antibodies and antigens have not 
been identified. One component of the pathology of these alopecias 
is an apparent reduction in the capillary network of hair bulbs that 
accompanies normal growth [7] . Because monocyte/macrophages 
play important roles in inflammatory and immune responses, as 
well as in elaborating cytokines that modulate growth and differen-
tiation, it was postulated that abnormality in the function of these 
cells, especially with respect to elaboration of the monocyte-derived 
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these alopecias. Purified preparations of monocytes were ac-
tivated in culture. Conditioned media were assessed for an-
giogenic activity on the chick chorioallantoic membrane and 
for concentration of TNFa by enzyme-linked immunosor-
bent assay (ELISA) . Both angiogenic and the TNF concen-
tration were significantly diminished in conditioned media 
from AU monocytes when compared to those from normal 
subjects and patients with AA. These results show that the 
function of AU monocytes may be abnormal' and that the 
abnormality may distinguish AU from AA. Defective mono-
cyte/macrophage function could also play a pathogenic role 
via effects on neovascularization and/or modulation of the 
immune response.] InvestDermato/95:139 -143, 1990 
angiogenic factor, tumor necrosis factor (TNFa) , might play a role 
[8,9] . 
Accordingly, we investigated the angiogenic activity and levels of 
TNFa in media from cultures of peripheral blood monocytes from 
patients with AA, AT, and AU in comparison to those from normal 
subjects. 
METHODS 
Subjects Control subjects were normal adult volunteers without 
known diseases of the skin or hair, autoimmune diseases, or im-
mune-deficiency diseases. Patients with AU, AT, and AA were 
drawn from the outpatient clinics of Northwestern Medical Faculty 
Foundation or recruited through the auspices of the Alopecia Areata 
Foundation. Venous blood was obtained after informed consent. 
Preparation of Monocytes One hundred thirty milliliters of 
venous blood was collected with ethylenediamino tetra acetate acid 
(K3) as anticoagulant and centrifuged for 10 min at 500 Xg, and 
the plasma was removed. Sepracell MN (Sepratech Corp., OK) was 
added to the packed cells (0.6 voljvol) and centrifuged for 25 min at 
1500 X g, at room temperature in a Beckman TJ6 centrifuge with a 
swinging bucket rotor. The monocyte fraction was removed with a 
siliconized pasteur pipette, mixed with PBS-0.1 % BSA (1: 4), and 
centrifuged for 15 min at 100 X g. The pellet was resuspended with 
PBS-BSA and Sepracell (1: 1) and centrifuged for 25 min at 
1500 X g. 
Monocytes were harvested, washed again with PBS-BSA, and 
centrifuged for 10 min at 300 X g. Cells were suspended in Dul-
becco's modified Eagle medium containing 5 ,Llgjml gentamycin 
(DMEM) with 10% fetal calf serum (FCS) and were counted. The 
average yield was 1.1 X 106 monocytes/ 10 ml blood. Viability was 
> 98% as judged by exclusion of trypan blue. Purity of the mono-
cyte preparations was assessed by morphology of cytocentrifuged 
preparations of aliquots of suspended cells stained with Diff-Quick 
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and by non-specific esterase localization as identified by naphthyl 
acetate. By these methods preparations were shown to be at least 
90% pure monocytes. 
Culture and Activation of Monocytes with Endotoxin 
[10] 2 X 106 cells in DMEM with 10% FCS were plated in 5 ml 
culture dishes. Plates were incubated for 3 h at 37"C in a moist 
incubator gassed with 5% C02/95% air and then washed with 
DMEM. Monocytes adherent to the plates were cultured overnight 
with DMEM with 10% FCS and then washed 3 times with DMEM. 
Cells were then cultured for 24 h with DMEM with 0.5% FCS 
with or without 5 .ug/ml bacterial endotoxin (phenol extracted 
preparation of Escherichia coli 055: BS lipopolysaccharide [LPS}, 
Sigma Corp.). Media were collected and concentrated tenfold by 
ultrafiltration on centricon microconcentrators (10 kM cut off) and 
were stored at -70oC. 
Chick Chorioallantoic Membrane Assay (CAM) for Angio-
genesis This assay was performed as described by Leibovich and 
Polverini (11 ]. One vol of concentrated (10 times) conditioned cul-
ture medium was mixed with 9 vol of 0.5% methyl cellulose in 
H 20 . Ten microliters of this mixture was applied to the square-cut 
ends of 2-mm teflon rods and dried at room temperature to form 
thin pellets. 
Fertilized chick eggs were removed from their shells on the third 
day of gestation and transferred to sterile plastic film cradles. The 
eggs were incubated for 7 d at 3 7 o C in a humidified incubator. Four 
pellets from each conditioned-medium sample were explanted onto 
each of two or three developing CAM of the 10-d-old chick em-
bryos. Care was taken to place pellets on areas free of major vessels. 
Growd1 of new blood vessels around the pellets was assessed at 72 h 
under a Wild MSA stereoscopic microscope (Heerburg, Switzer-
land) . Angiogenic activity was graded by two unbiased observers on 
a scale of 0 to 4+ by previously published criteria for angiogenic 
activity (11,12]. Membranes were fixed in 10% buffered formalin 
for later photography. 
Assay ~f TNFa This assay was performed with the Endogen 
TNFa-ELISA kit (Endogen Inc., Boston) according to the manu-
facturer's instructions. Unconcentrated conditioned media from 
control and patient monocytes were used, with DMEM as negative 
control. In brief, triplicate 1 00-,UI samples of medium were added to 
microwells that had been coated with the anti-TNFa monoclonal 
antibody and incubated overnight. After thorough washing, poly-
valent rabbit anti-TNF antibody was added for a 1-h incubation, 
followed by incubation with phosphatase-linked goat anti-rabbi~ Ig 
antibody for 1 h. After thorough washmg, the substrate reactton 
was performed with para-nitrophenyl phosphate. Absorbance of 
each well was read at 15-min intervals for 90 min at 405-410 nm 
in a Bio Rad ELISA plate reader. Concentrations were determined 
against a standard curve of TN Fa. 
RESULTS 
Angiogenic activity produced by the monocytes o~ 15 ~ormal sub-
jects, nine patients with AU, t:Vo wtth AT, and stx w1t~1 AA, was 
examined. All AU and AT pauents had long-standmg dtsease, and 
none were on systemic medications. AA patients were in vario~s 
stages of the disease, but none were in remission or on systemic 
medication. 
Figure 1 illustrates typical angiogenic responses in the subjects 
studied, scored on a scale of 0-4 +. 
Resu lts of the CAM assay of conditioned media from LPS-acti-
vated monocytes are summarized in Table I. Data are presented as: 
a) mean of the percentage of media impregnated pellets with angto-
genic activity (1 + or more) for each subject and b) mean of the 
average scores (sum of scores/total number of pellets) for each sub-
ject. Statistical significance was derived by Student t tests. 
The percent of pellets with angiogenic activity (1 + or great~r) 
was nearly 4 times as great in control subjects as that of patients wtth 
AU (p < 0.001) and the two patients with A-r: alsoshowed lower 
activity. Whereas AA pellets had less angtogemc acuvtty than con-
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trois, this difference was not statistically significant; however, ~ 
giogenic activity was significantly greater when compared to A~ 
pellets (p < 0.01). 
The mean score was also markedly different between control an~ 
AU (1.6 vs 0.2, p < 0.001) . AA had a mean score ofl.O, which w 
not different from contr?ls but .was significan.tly. higher than A~ 
(p < 0.01). The two pattents wtth AT were stmtlar to those wit~ 
AU. The differences are underscored by data on individual subjec~ 
only one control subject had a mean score of< 1 +,and one oth~ 
control subject had fewer than 50% positive pellets. Only one of s~ 
patients with AA had less than 50% positive pellets and a mean sco~ 
of < 0.4. In contrast, none of the AU patients had more than 38'\ 
positive pellets or a mean score of more than 0.4. 
CAM assays were also performed with conditioned media fro 
non-activated cells (cultured without LPS) from each subject. The~ 
was some angiogenic activity but mean scores were less than 0.2 :i 
0.1. Pellets impregnated only with unconditioned medium we~ 
always negative. 
The concentrations ofTNFa in conditioned media as assessed b~. 
ELISA are shown m Table II. Media from control cells had mo~ 
than twice the amoun~ of TNFa than those from AU (p < 0.01) 
AA medta were not dtfferent from controls and the two patienh 
with AT fell in between control and AU values. ""~ 
To determine whether the angiogen~c response i?.the CAM assa~ 
could be attnbuted to levels of TNFa m the cond1t10ned mediun\ 
we correlated these two parameters for the 29 subjects in who!\)_ 
both were assessed (Fig 2) . Correlation between pg/ml TNFa an~ 
angiog~nic score w~s stat~stica~l">: significant (r = 0.52, p < 0.01) 
suggestmg that angwgemc act1v1ty reflected the concentration 0t 
TN Fa. Thus, reduced angiogenic activity in medium from LPS-ac 
tivated monocytes from patients with AU may be attributable t~ 
reduced generation of active TNFa by these cells. 
DISCUSSION 
The present studies show that there may be an abnormality in circu 
lating monocytes from patients with AU (and possibly AT). Condi \ 
tioned media from cultures of AU monocytes activated with endo' 
toxin contain less TNFa and angiogenic activity than media fro~ 
cultured normal monocytes. The correlation between TNFa an~ 
angi~genesis in the CAM assay suggests that the defect reflects, a~ 
least 111 part, a reduced generation ofTNFa. However, we cann0 r~le ?ut the possibility that .the results m~y be due to inactivation 0~ 
bmdmg ofTNFa. by an mhtbttory factor m such a way as to make i~ 
ept.tope unrecogmzable by ELISf.>. It is also p~ssible t~at ot~er, ~ ye~ 
umdenttfied, factors modulated 111 parallel wtth ang10gemc acttvit), 
and TNFa may play a role. · 
Th~ st~dy also suggests that this abnormality is not shared, at leas~ 
quantttattvely, by monocytes from patients with AA. If this differ, 
ence is confirmed by further studies, these results would suggest tha~ 
there may be laboratory methods for distinguishing the local froll\ 
the generalized form of these disorders and that there may be patho.. 
genetic distinctions. · 
The signific~nce of the demonstrated abnormality for the patho.. 
genesiS of AU 1s not clear. Although most of the current evidenct-
supports the view that these alopecias represent autoimmune pro.. 
cesses, with a strong association with other autoimmune diseases 
the nature of the antigenic stimulus is unknown, and pathogeni~ 
mechanisms have not been entirely elucidated. Infiltrates aroun~ 
affected hair contain activated T cells [1 ,2) and keratinocytes of the 
bulbar precortical matrix and presumptive cortex express HLA DR. 
(3,4) . Recent studies [13] suggest that the presence of activated 
lymphoid cells may provide the trigger for expression of HLA DR 
on bulbar keratinocytes, leading to amplification of the immune 
response in which the target cell is the bulbar epithelium. Tht 
contribution of Langerhans cells, which are present in the bulbar 
epithelium (5,6] , has not been defined. It is possible that macro-
phages may play a significant role in initial and/ or subsequent 
events in rhe process that damages the hair follicle and abnormalitii'S 
in their function could be important components of this process. 
Although a variety of abnormalities have been described in circu· 
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Table I. Angiogenic Activity in the CAM Assa)"' 
% Positiveb Score' 
Subject Number ±SE ±SE 
Control 15 76 ± 5 1.6 ± 0.2 
Arcata 6 56 ±10 1.0 ± 0.2 
Universal is 9 19 ± 4 0.2 ± 0.1 
Total is 2 36 ±27 0.5 ± 0.4 
Control vs arcata p > 0.1 > 0.1 
Control vs universalis p < 0.001 < 0.001 
Arcata vs universalis p < 0.01 < 0.01 
• Assay performed, as described in the text, on conditioned medium from monocytes 
cultured with LPS. Medium without LPS had < 10% positive and scores < 0.2 for all 
subjects. 
1 % positive: mean of% positive (2: 1 +) pellets/ patient. 
' Mean score: mean of average score/patient. Average score= total score (0 -4)/total 
number of pellets. 
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Figure 1. Photomicrographs of typical responses in CAM assay with meth-
ylcellulose pellets impregnated with 10 ,ul conditioned medium from cul-
tured monocytes. Positive response is defined as the unidirectional ingrowth 
of capillary loops and sprouts towards the pellet. a) negative response; b) 1 +, 
a few sprouts and loops (i) under the pellet; c) 2 + , sprouts and loops moving 
towards the center of the pellet (i); d) 3 +,vessels are also radiating towards 
the pellet from the periphery; e) 4 +, most intense response with pellet 
surrounded by ingrowing vessels . Magnification X9. 
lacing lymphocytes, none of these can be readily assigned a primary 
role in the pathogenic sequence. T-cellnumbers have been reported 
to be either normal [14,15] or decreased [16-18]; blastogenic re-
sponses to mitogens have been reported to be decreased [17, 18] or 
normal [15]; cell-mediated cytotoxicity has been reported to be 
increased in AU [19]. Circulating antibodies against hair follicles or 
lymphocyte responses against hair-associated antigens have not 
been demonstrated [ 14- 18,20). although there is a report of anti-
bodies against endothelial cells of the hair bulb capillary plexus in 
AA (21]. · 
Although macrophages are present in the perifollicular inflam-
matory infiltrate, they have received little attention, and monocytes 
have not previously been studied. Monocytes/macrophages are of 
interest in these conditions not only because of their pivotal role in 
regulation oflymphocytes in the immune response, but also because 
macrophage-derived cytokines directly influence function of cells 
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Table II. TNFa Concentration in Conditioned Medium of 
Cultured Monocytes Activated with LPS• 
Subject 
Control 
Arcata 
Universal is 
Totalis 
Control vs arcata 
Control vs universalis 
Arcata vs universalis 
Number 
13 
6 
8 
2 
TN Fa 
pg/ml ±SE 
5.4 ± 0.7 
5.8 ± 1.0 
2.3 ± 0.6 
4.4 ± 0.5 
p > 0.1 
p < O.Dl 
p < 0.01 
• Assay performed as described in the text on conditioned media from cultured 
monocytes activated with LPS. Each medium was tested in triplicate wells and results 
represent the means of values for all media tested in each category. 
other than those of the immune system. One such factor is TNFa, 
which has been identified as the principal monocyte/macrophage-
derived angiogenic factor (9] and which has been implicated in the 
neovascularization of wound healing, tumor growth, and chronic 
inflammation [10,22-24]. 
In this regard it is of interest that the anagen phase is associated 
with angiogenesis, as demonstrated by enhanced DNA synthesis in 
the peribulbar capillary endothelium [25]. Hoekel et a! have re-
ported that a purified monocyte-derived angiotropin induces angio-
genesis and hair growth when injected intradermally (26]. Ma-
jewski et al (27] have demonstrated an increased amount of 
neovascularization when allogenic splenocytes are injected into 
mice during anagen IV. These reports raise the intriguing possibil-
ity that cells of the immune system may play a role in hair growth, 
although it is generally believed that the growth factors associated 
with the anagen phase originate with the hair bulb or associated 
dermal papilla. Indeed, isolated anagen bulbs have been shown to 
induce angiogenic activity [28], although the cellular origin of this 
activity 'has not been identified. TNFa is not an endothelial cell 
mitogen (9,29), but rather acts as an angiogenic agent by activating 
endothelial cells and inducing their migration. It is possible that the 
interaction of monocytes/macrophages with the hair bulb involves 
the stimulation of endothelial cell growth factors in the hair bulb 
itself by action of macrophage-derived factors such as TNFa. 
TNFa has been shown to induce expression of growth factors and 
MHC by several cell types [30,31] . Such an effect on hair bulbs 
might play a role in modulating endothelial cell proliferation and 
angiogenic activity. 
Moreover, because the capillary network of anagen hair bulbs 
regresses during the telogen phase.' the signifi~ance of r~duced va~­
cularity [7] and blood flow (32] ~n scalps w1th al<?pec1a are~ta 1s 
difficult to assess with respect to pnmary pathogenetic mechamsms. 
Conditioned Media from CIJitxed Monoeytea: 
10 3 
c-..,..ollon of TNF o< 0 
Anglogonoolo h 1tw CAM Auor el 2.6 
8 
Figure 2. Comparison of results of CAM assay and concentration TN Fa. 
Angiogenic scores and pg ofTNFa derived from Tables I and II. Open bars, 
CAM assay± SE. Hatched bars, pg TNFa:/ml medium. 
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Thus, whether the reduced angiogenic activity of AU rnono.. 
cytes, even if shared by macrophages in the inflammatory infiltratt 
bears directly on the pa~hologic mechanism cannot be assessed 0~ 
the basis of present data. Abnormalities in the production ofTNF(\ 
by monocyte/macrophages may have other implications for growt~ 
of affected hairs because this growth factor has been implicated as~ 
cytokine that modulates differentiation (33,34]. Finally, these stud, 
ies addressed only the generation of angiogenic factor by monocytC!\ 
activated with LPS. It is not yet known whether the altered behav, 
ior of AU monocytes reflects a specific defect of monocyte activa, 
tion or a more generalized abnormality in monocyte/macrophages 
Moreover, these studies have not addressed the state of tissue macr~ 
phages or macrophage/lymphocyte interactions. These questio~ 
are subjects of ongoing investigations. 
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NIH CONSENSUS PANEL ISSUES REPORT 
A National Institutes of Health consensus development statement on Sunlight, Ultraviolet 
Radiation, and the Skin may be obtained from the NIH Office of Medical Applications of 
Research. 
The report was prepared by a panel of experts who considered scientific evidence presented at 
Consensus Development Conference at NIH. It contains recommendations and conclusions 
concerning the effects of sunlight and ultraviolet radiation on the skin. 
At NIH, consensus conferences bring together researchers, practicing physicians, representa-
tives of public interest groups, consumers, and others to carry out scientific assessments of drugs, 
devices, and procedures in an effort to evaluate their safety and effectiveness. 
Free, single copies of the consensus statement on the effects of sunlight and ultraviolet 
radiation on the skin may be obtained from: William H. Hall, Director of Communications, 
Office of Medical Applications of Research, National Institutes of Health, Building 1, Room 
259, Bethesda, Maryland 20892. 
